{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-006615","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2026-10-14T12:00:36+00:00","discovered_at":"2026-10-14T12:05:00.270300+00:00","generated_at":"2026-10-14T12:05:08.027837+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Profound Medical touts TULSA data at iMRI Symposium; CAPTAIN shows 2.1x functional preservation vs robotic RP","bullets":["CAPTAIN randomized trial: whole-gland TULSA patients 2.1x more likely to preserve erectile function and pad-free continence vs robotic prostatectomy (p=0.004); hospitalizations 0.7% vs 6.3%.","CARE Registry (197 patients, 5 centers, median 24-mo follow-up): median PSA nadir 0.23 ng/mL whole-gland vs 0.60 subtotal vs 1.10 focal; catheterization 13.5 days vs 7 days.","Mayo Clinic Florida: 58 patients up to 4.5 years; 100% pad-free and 94% leak-free continence, 87.5% potency beyond 12 months; median PSA nadir 0.9 ng/mL; 12% needed secondary treatment.","Mayo Clinic Rochester: 41 patients, mean PSA fell roughly 62-66% from 7.7 ng/mL through one year; biopsy-confirmed recurrence in 22% (12% in-field, 10% out-of-field).","Siemens 0.55T Free.Max platform validated: 3D thermometry precision up 40%, targeting accuracy 1.0±0.9 mm; no FDA clearance or commercial availability claimed."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-006615","json":"https://secwatch.observer/filing/0001171843-26-006615.json","markdown":"https://secwatch.observer/filing/0001171843-26-006615.md","text":"https://secwatch.observer/filing/0001171843-26-006615.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326006615/0001171843-26-006615-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326006615/f8k_101426.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-14T12:05:08.027837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}